AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

VERSARIEN PLC

Declaration of Voting Results & Voting Rights Announcements Mar 31, 2020

8006_rns_2020-03-31_dc31bf1e-5f29-4b77-a091-ce330674ab3d.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1226I

Versarien PLC

31 March 2020

31 March 2020

Versarien Plc

("Versarien", the "Company" or the "Group")

Total Voting Rights  

Versarien plc (AIM: VRS), the advanced materials engineering group, announces, that that in conformity with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority ("FCA"), the Company's issued share capital consists of 169,682,290 Ordinary Shares of 1p each with full voting rights.

The figure of 169,682,290 may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Enquiries:

Versarien

Neill Ricketts, CEO

Chris Leigh, CFO
+44 (0)1242 269 122
SP Angel Corporate Finance (Nominated Adviser and Joint Broker)

Ewan Leggat, Soltan Tagiev
+44 (0)20 3470 0470
Berenberg (Joint Broker)

Mark Whitmore, Simon Cardron
+44 (0) 20 3207 7800
Yellow Jersey (Investor Relations) 

Charles Goodwin

Georgia Colkin

Henry Wilkinson
+44 (0)20 3004 9512

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

TVRKKKBQABKDDNN

Talk to a Data Expert

Have a question? We'll get back to you promptly.